| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Cytarabine | CTRPv2 | pan-cancer | AAC | -0.0087 | 0.8 |
| mRNA | ML203 | CTRPv2 | pan-cancer | AAC | 0.012 | 0.8 |
| mRNA | WP1130 | CTRPv2 | pan-cancer | AAC | -0.011 | 0.8 |
| mRNA | PHA-665752 | GDSC1000 | pan-cancer | AAC | -0.015 | 0.8 |
| mRNA | Vorinostat | CTRPv2 | pan-cancer | AAC | -0.0097 | 0.8 |
| mRNA | indisulam | CTRPv2 | pan-cancer | AAC | -0.0093 | 0.8 |
| mRNA | CAY10603 | GDSC1000 | pan-cancer | AAC | 0.009 | 0.8 |
| mRNA | salermide | CTRPv2 | pan-cancer | AAC | -0.013 | 0.8 |
| mRNA | AUY922 | GDSC1000 | pan-cancer | AAC | -0.01 | 0.8 |
| mRNA | rigosertib | CTRPv2 | pan-cancer | AAC | -0.0092 | 0.8 |